Scopus (CiteScore 2022 =3.0, Q3) , ISC

Document Type : Case Report

Authors

1 Clinical Pathology Education Program, Hematology Division, Faculty of Medicine, Airlangga University, Surabaya, Indonesia

2 Clinical Pathology Department, Faculty of Medicine, Airlangga University, Surabaya, Indonesia

3 Anatomical Pathology Laboratory, Dr. Saiful Anwar General Hospital, Malang, Indonesia

4 Clinical Pathology Laboratory, Brawijaya University, Malang, Indonesia.

10.48309/ecc.2024.424662.1730

Abstract

Pleural effusion in sporadic Burkitt's lymphoma is very rare. The diagnosis of Burkitt's lymphoma was confirmed by histopathological and immunohistochemical examination, while pleura involvement was confirmed by pleural fluid analysis and its cytology. We presented a 6-year-old girl diagnosed with Burkitt's lymphoma who came for the sixth cycle of chemotherapy presented with shortness of breath. Lymphoma cell infiltration was confirmed by immunohistochemical examination of the mass in the ileum and pleural fluid cytology. Although rare, the possibility of lymphoma cell infiltration should be considered if a pleural effusion is found in Burkitt's lymphoma.

Graphical Abstract

Pleural efusion in burkitt’s lymphoma: a case report

Keywords

Main Subjects

[1] M.R. Lokeshwar, N.K. Shah, A. Sachdeva, B.R. Agarwal, M.V., Pillai A. Manglani, Textbook of Pediatric Hematology and Hemato-Oncology [Internet], Jaypee Brothers Medical Publishers (P) Ltd.; 2016. [Crossref], [Google Scholar], [Publisher]
[2] H. Istiadi,  U. Sadhana, D. Puspasari, I.P. Miranti, V. Karlowee, D.E. Listiana, A. Prasetyo, Prognostic significance of double expressor lymphoma subtype in patient with diffuse large B-cell lymphoma, Bali Medical Journal, 2021, 10, 366-372. [Crossref], [Google Scholar], [Publisher]
[3] G. Khusnurrokhman L. Wulandari Mediastinal Non-Hodgkin’s Lymphoma Metastatic to Right Atrium Mimicking Right Atrial Myxoma, Folia Medica Indonesiana, 2021, 57, 345-350. [Crossref], [Google Scholar], [Publisher]
[4] R.S. Salma, M.P. Sedana, S.U. Yudho, CHOP and R-CHOP Therapeutic Responses in Non-Hodgkin Lymphoma Patients in Dr. Soetomo General Hospital Surabaya, Biomolecular and Health Science Journal, 2018, 1, 93-96. [Crossref], [Google Scholar], [Publisher]
[5] D. Muduly, T. Subi, N. Shukla, S. Deo, A. Kallianpur, An update in the management of malignant pleural effusion, Indian Journal of Palliative Care, 2011, 17, 98. [Crossref], [Google Scholar], [Publisher]
[6] R. Hashempour, , Aryannia, A., M. Mehrjerdian, S.S. Baniaghil, A. Rezaie, R. Alipoor, The Concentration of Interleukin-27 in the pleural fluid of patients with exudative pleural effusion and its diagnostic value in differentiating between benign and malignant pleural effusion, Bali Medical Journal, 2018, 7, 205-209. [Crossref], [Google Scholar], [Publisher]
[7] (a) Y. iang,  W. Xie, K.  Hu, J. Sun,  X. Zhu, H. Huang,  An aggressive form of non-Hodgkin’s lymphoma with pleural and abdominal chylous effusions: A case report and review of the literature, Oncology Letters, 2013, 6, 1120-1122. [Crossref], [Google Scholar], [Publisher], (b) M.K. Najim, Q.R. Lahhob, H.J. Abbas, H.A. Alidrisi, Z.J. Ibrahim, Z.K. Budaiwi, Z.H. Abdul-Jabbar, Association of serum apelin and atherogenic indices in patients with primary thyroid diseases, Journal of Medicinal and Pharmaceutical Chemistry Research, 2023, 5, 588-597. [Pdf], [Google Scholar], [Publisher], (c) J. Nourmohammadi, M. Jafari, R. Abbaszadeh, S. Rahimi Ghasabeh, H. Amani, S.A. Kalali Sani, Chest CT findings in patients with COVID-19 infection: a systematic review and meta-analysis, Journal of Medicinal and Pharmaceutical Chemistry Research, 2022, 4, 425-431. [Pdf], [Google Scholar], [Publisher], (d) A. Zafar-Mohtashami, A. Bakhtiari, B. Hadian, Z. Obeidavi, Nephrotic syndrome associated with carcinoma of unknown primary treated with chemotherapy: A rare case report, , Journal of Medicinal and Pharmaceutical Chemistry Research, 2020, 2, 196-201. [Pdf], [Google Scholar], [Publisher]
[8] R. Jaffe, WHO classification of tumours of haematopoietic and lymphoid tissues, World Health Organization Classification of Tumours,2008,  358-360. [Google Scholar], [Publisher]
[9] G.     Lenz, L.M. Staudt,  Aggressive lymphomas, New England Journal of Medicine2010, 362, 1417-1429. [Crossref], [Google Scholar], [Publisher]
[10] A. Septiani P.P.A.P. Dewi, Widyoningroem A., Sensusiati A.D., Yamin M., The relationship between Epidermal Growth Factor Receptor (EGFR) mutation and computed tomography findings in lung adenocarcinoma, Bali Medical Journal, 2019, 8, 511-514. [Crossref], [Google Scholar], [Publisher]
[11] S.S. Chuang,  H. Ye,  M.Q. Du,  C.L. Lu, A. Dogan,  P.P. Hsieh, W.T. Huang, Y.C. Jung, Histopathology and immunohistochemistry in distinguishing Burkitt lymphoma from diffuse large B-cell lymphoma with very high proliferation index and with or without a starry-sky pattern: a comparative study with EBER and FISH, American journal of clinical pathology2007, 128, 558-564. [Crossref], [Google Scholar], [Publisher]
[12] K. Kelemen,  R.M. Braziel, K. Gatter, T.C. Bakke, S. Olson, G. Fan, Immunophenotypic variations of Burkitt lymphoma, American journal of clinical pathology2010, 134, 127-138. [Crossref], [Google Scholar], [Publisher]
[13] B. Askandar,  Lung metastasis of gynecologic cancers, Bali Medical Journal, 2021,  10, 701-707. [Crossref], [Google Scholar], [Publisher]
[14] H. Yu, March. Management of pleural effusion, empyema, and lung abscess. In Seminars in Interventional radiology, 2011,   28, 75-86. [Crossref], [Google Scholar], [Publisher]
[15] I. Asmara, Clinical and laboratory comparison between End-Stage Kidney Disease patients with and without COVID-19: a cross-sectional study in a top referred hospital of West Nusa Tenggara, Bali Medical Journal2022, 11, 1074-1079. [Crossref], [Google Scholar], [Publisher]
[16] E.A. Pangarsa, D. Rizky,  B. Setiawan,  D. Santosa,  S.M. Haryana, C. Suharti,  Crosstalk between hypoxia and inflammation in non-Hodgkin lymphoma, Bali Medical Journal, 2022,  11, 1063-1073. [Crossref], [Google Scholar], [Publisher]
[17] J.A. Kastelik, Management of malignant pleural effusion. Lung, 2013, 191, 165-175. [Crossref], [Google Scholar], [Publisher]
[18] R.M. Mercer, J.P. Corcoran, J.M. Porcel, N.M. Rahman, I. Psallidas, Interpreting pleural fluid results, Clinical Medicine, 2019, 19, 213. [Crossref], [Google Scholar], [Publisher]
[19] W.Q. Zheng, Z.D. Hu, Pleural fluid biochemical analysis: the past, present and future, Clinical Chemistry and Laboratory Medicine (CCLM), 2023, 61, 921-934. [Crossref], [Google Scholar], [Publisher]
[20] J. Ritter, L. Lewis, T. Mant, A. Ferro, A textbook of clinical pharmacology and therapeutics, CRC Press, 2008. [Crossref], [Google Scholar], [Publisher]